The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $404.28

Today's change-1.13 -0.28%
Updated July 2 4:00 PM EDT. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $404.28

Today's change-1.13 -0.28%
Updated July 2 4:00 PM EDT. Delayed by at least 15 minutes.

Biogen Inc down (U.S.)$1.13

Biogen Inc closed lower Thursday, dropping (U.S.)$1.13 or 0.28% to (U.S.)$404.28. Shares have lost 1.70% over the last five days, but have gained 19.10% over the last year to date. This security has outperformed the S&P 500 by 16.97% during the last year.

Key company metrics

  • Open(U.S.) $407.29
  • Previous close(U.S.) $405.41
  • High(U.S.) $407.98
  • Low(U.S.) $403.15
  • Bid / Ask-- / --
  • YTD % change+19.10%
  • Volume929,142
  • Average volume (10-day)1,304,957
  • Average volume (1-month)1,278,046
  • Average volume (3-month)1,564,889
  • 52-week range(U.S.) $290.85 to (U.S.) $480.18
  • Beta0.94
  • Trailing P/E29.18×
  • P/E 1 year forward24.21×
  • Forward PEG1.44×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $13.85
Updated July 2 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+32.49%

Based on its net profit margin of 32.49%, Biogen Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue2,5552,6412,5112,421
Total other revenue--------
Total revenue2,5552,6412,5112,421
Gross profit2,2432,3432,2092,130
Total cost of revenue312297303292
Total operating expense1,4371,4811,3591,433
Selling / general / administrative560574570577
Research & development461500417447
Depreciation / amortization96107122117
Interest expense (income), net operating--------
Unusual expense (income)83-540
Other operating expenses, total--000
Operating income1,1181,1601,153989
Interest income (expense), net non-operating-7-7-7-7
Gain (loss) on sale of assets--------
Other--------
Income before tax1,1031,1511,136994
Income after tax821883862725
Income tax, total282268275269
Net income823883857715
Total adjustments to net income--------
Net income before extra. items823883857715
Minority interest211-9
Equity in affiliates-10-5-2
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items823883857715
Inc. avail. to common incl. extra. items823883857715
Diluted net income823883857715
Dilution adjustment--0----
Diluted weighted average shares236236237237
Diluted EPS excluding extraordinary itemsvalue per share3.493.743.623.01
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share3.523.753.443.01